Study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion

Objective: To analyze the recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion. Methods: A total of 92 cases of children with febrile convulsion who received treatment in our hospital from March 2012 to December 2014 were selected as research subjects a...

Full description

Bibliographic Details
Main Author: Hui-Qin Meng
Format: Article
Language:English
Published: Editorial Board of Journal of Hainan Medical University 2016-05-01
Series:Journal of Hainan Medical University
Subjects:
Online Access:http://www.hnykdxxb.com/PDF/201609/21.pdf
id doaj-a214a1d8c001478db17cb23cf3d9b8b4
record_format Article
spelling doaj-a214a1d8c001478db17cb23cf3d9b8b42020-11-24T21:01:13ZengEditorial Board of Journal of Hainan Medical UniversityJournal of Hainan Medical University1007-12371007-12372016-05-012298386Study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsionHui-Qin Meng0Department of Pediatric Neurology, Jiaozuo Maternal and Child Health Care Hospital, Jiaozuo City, Henan Province, 454000Objective: To analyze the recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion. Methods: A total of 92 cases of children with febrile convulsion who received treatment in our hospital from March 2012 to December 2014 were selected as research subjects and randomly divided into observation group and control group according to different treatment methods, each group with 46 cases. Control group received conventional therapy, observation group received levetiracetam combined with conventional therapy, and then differences in recurrence of febrile convulsion, cranial nerve-related factors, contents of trace elements and iron as well as humoral and cellular immune function of two groups were compared. Results: Average number of fever, frequency of recurrence of convulsion and the proportion of developing to epilepsy of observation group after treatment were less than those of control group, and the time from the end of treatment to the first convulsive seizure was longer than that of control group; serum NSE, S-100β and BDNF levels of observation group fter treatment were lower than those of control group; serum Ca2+, P, SI and SF levels of observation group after treatment were higher than those of control group, and ALP level was lower than that of control group; serum IgA, IgM, IgG and CD8+ levels of observation group after treatment were lower than those of control group, and levels of CD4+ and CD4+/ CD8+ were higher than those of control group. Conclusion: Levetiracetam therapy for children with febrile convulsion reduces convulsive seizure and meantime can optimize children’s microenvironment and enhance immune function. http://www.hnykdxxb.com/PDF/201609/21.pdfFebrile convulsionLevetiracetamRecurrenceSerum indicators
collection DOAJ
language English
format Article
sources DOAJ
author Hui-Qin Meng
spellingShingle Hui-Qin Meng
Study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion
Journal of Hainan Medical University
Febrile convulsion
Levetiracetam
Recurrence
Serum indicators
author_facet Hui-Qin Meng
author_sort Hui-Qin Meng
title Study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion
title_short Study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion
title_full Study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion
title_fullStr Study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion
title_full_unstemmed Study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion
title_sort study of recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion
publisher Editorial Board of Journal of Hainan Medical University
series Journal of Hainan Medical University
issn 1007-1237
1007-1237
publishDate 2016-05-01
description Objective: To analyze the recurrence and serum indicator change after levetiracetam treatment of children febrile convulsion. Methods: A total of 92 cases of children with febrile convulsion who received treatment in our hospital from March 2012 to December 2014 were selected as research subjects and randomly divided into observation group and control group according to different treatment methods, each group with 46 cases. Control group received conventional therapy, observation group received levetiracetam combined with conventional therapy, and then differences in recurrence of febrile convulsion, cranial nerve-related factors, contents of trace elements and iron as well as humoral and cellular immune function of two groups were compared. Results: Average number of fever, frequency of recurrence of convulsion and the proportion of developing to epilepsy of observation group after treatment were less than those of control group, and the time from the end of treatment to the first convulsive seizure was longer than that of control group; serum NSE, S-100β and BDNF levels of observation group fter treatment were lower than those of control group; serum Ca2+, P, SI and SF levels of observation group after treatment were higher than those of control group, and ALP level was lower than that of control group; serum IgA, IgM, IgG and CD8+ levels of observation group after treatment were lower than those of control group, and levels of CD4+ and CD4+/ CD8+ were higher than those of control group. Conclusion: Levetiracetam therapy for children with febrile convulsion reduces convulsive seizure and meantime can optimize children’s microenvironment and enhance immune function.
topic Febrile convulsion
Levetiracetam
Recurrence
Serum indicators
url http://www.hnykdxxb.com/PDF/201609/21.pdf
work_keys_str_mv AT huiqinmeng studyofrecurrenceandserumindicatorchangeafterlevetiracetamtreatmentofchildrenfebrileconvulsion
_version_ 1716778499912499200